Pediatrix Medical Group, Inc. (MD)

Pediatrix Medical Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,922	2,013	1,995	1,972	1,911	1,734
Revenue Growth (YoY)	-4.21%	0.92%	1.15%	3.18%	10.22%	-2.57%
Cost of Revenue	1,426	1,559	1,573	1,505	1,398	1,285
Gross Profit	496.25	454.34	421.57	467.03	513.24	449.32
Selling, General & Admin	238.66	238.44	227.54	231.4	263.36	248.95
Operating Expenses	261.73	270.66	263.71	267.03	295.5	277.39
Operating Income	234.51	183.68	157.85	200	217.74	171.93
Interest Expense	-36.94	-40.74	-42.08	-39.7	-68.72	-110.48
Interest & Investment Income	17.18	5.77	4.34	3.67	13.65	17.91
Earnings From Equity Investments	3.71	2.34	2.06	1.72	1.91	1.59
EBT Excluding Unusual Items	218.46	151.05	122.17	165.7	164.58	80.95
Merger & Restructuring Charges	-40.03	-64.26	-2.22	-27.31	-22.1	-73.8
Impairment of Goodwill	3.6	-150.64	-148.31	-	-	-
Gain (Loss) on Sale of Investments	-	-	-20	-	-	-
Gain (Loss) on Sale of Assets	22.14	-9.7	-	-	7.28	-
Asset Writedown	-	-27.79	-	-	-	-
Other Unusual Items	-	-	-	-57.02	-14.53	-
Pretax Income	204.17	-101.34	-48.36	81.37	135.23	7.15
Income Tax Expense	41.98	-2.27	12.05	18.81	27.24	16.73
Earnings From Continuing Operations	162.19	-99.07	-60.41	62.56	107.99	-9.58
Earnings From Discontinued Operations	-	-	-	3.77	22.95	-786.91
Net Income to Company	162.19	-99.07	-60.41	66.33	130.94	-796.49
Minority Interest in Earnings	-	-	-	0	0.03	-
Net Income	162.19	-99.07	-60.41	66.34	130.96	-796.49
Net Income to Common	162.19	-99.07	-60.41	66.34	130.96	-796.49
Net Income Growth	-	-	-	-49.35%	-	-
Shares Outstanding (Basic)	84	83	82	83	85	83
Shares Outstanding (Diluted)	85	83	82	84	86	83
Shares Change (YoY)	2.48%	1.37%	-2.28%	-1.99%	2.92%	-0.73%
EPS (Basic)	1.92	-1.19	-0.73	0.79	1.54	-9.55
EPS (Diluted)	1.91	-1.19	-0.73	0.78	1.53	-9.55
EPS Growth	-	-	-	-48.62%	-	-
Free Cash Flow	273.39	184.55	104	137.23	44.49	175.83
Free Cash Flow Per Share	3.21	2.21	1.26	1.63	0.52	2.11
Gross Margin	25.81%	22.57%	21.14%	23.68%	26.86%	25.91%
Operating Margin	12.20%	9.13%	7.91%	10.14%	11.39%	9.92%
Profit Margin	8.44%	-4.92%	-3.03%	3.36%	6.85%	-45.93%
Free Cash Flow Margin	14.22%	9.17%	5.21%	6.96%	2.33%	10.14%
EBITDA	257.58	215.91	194.02	235.64	249.89	200.37
EBITDA Margin	13.40%	10.73%	9.73%	11.95%	13.08%	11.56%
D&A For EBITDA	23.07	32.23	36.17	35.64	32.15	28.44
EBIT	234.51	183.68	157.85	200	217.74	171.93
EBIT Margin	12.20%	9.13%	7.91%	10.14%	11.39%	9.92%
Effective Tax Rate	20.56%	-	-	23.11%	20.14%	234.02%

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q